IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: April 2024

Volume 9 | Issue 4

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Lambert eaton syndrome; a rare autoimmune disorder
Authors Name: Dr. Tanya Wadhwa , Dr. Ayush Pandey
Unique Id: IJSDR2306084
Published In: Volume 8 Issue 6, June-2023
Abstract: Lambert-Eaton syndrome (LES) or Lambert-Eaton myasthenic syndrome (LEMS), is a rare autoimmune disorder characterized by muscle weakness and impaired neuromuscular transmission. The case report being presented is of a 56-year-old female patient who complained of progressive muscle weakness, and autonomic dysfunction. The patient’s symptoms posed a diagnostic challenge due to their overlapping features with other neuromuscular {myasthenia gravis} and autoimmune conditions. However, thorough clinical evaluation, electromyography (EMG), and serological testing, including the detection of P/Q-type voltage-gated calcium channel antibodies led to a confirmed diagnosis of LES. Management of this patient involved a multidisciplinary approach, involving neurologists and oncologists. Treatment plan focused on symptomatic relief and immunomodulatory therapy. The patient underwent physical therapy, respiratory assistance, and pharmacological interventions to manage symptoms associated with muscle weakness and autonomic dysfunction. Additionally, immunotherapy with intravenous immunoglobulins (IVIG) and potassium channel blockers, such as 3,4-diaminopyridine (3,4-DAP), was administered. Despite initial challenges in the diagnosis and management of LES, the patient demonstrated a favorable response to treatment, with gradual improvement in muscle strength and autonomic symptoms over time. Regular follow-up visits, along with adjustment to the treatment regimen, are essential to maintain disease stability and optimize the patient's quality of life. This case report highlights the importance of early recognition and accurate diagnosis of LES, particularly in patients with a history of malignancy. It emphasizes the significance of a comprehensive evaluation, including clinical assessment, electrophysiological studies, and serological testing, to differentiate LES from other neuromuscular disorders. Timely initiation of appropriate treatment strategies, encompassing both symptomatic relief and immunomodulatory therapy, can significantly improve patient outcomes and enhance their overall well-being. Further research and clinical studies are warranted to refine diagnostic criteria and optimize treatment protocols for Lambert-Eaton syndrome.
Keywords: Autoimmune P/Q type VGCC antibodies CALES NCALES CMAP amplitude IVIG 3, 4 DAP
Cite Article: "Lambert eaton syndrome; a rare autoimmune disorder", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 6, page no.578 - 579, June-2023, Available :http://www.ijsdr.org/papers/IJSDR2306084.pdf
Downloads: 000337351
Publication Details: Published Paper ID: IJSDR2306084
Registration ID:207144
Published In: Volume 8 Issue 6, June-2023
DOI (Digital Object Identifier):
Page No: 578 - 579
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner